Search Results - "REIMANN, F"

Refine Results
  1. 1

    SCFAs strongly stimulate PYY production in human enteroendocrine cells by Larraufie, P., Martin-Gallausiaux, C., Lapaque, N., Dore, J., Gribble, F. M., Reimann, F., Blottiere, H. M.

    Published in Scientific reports (08-01-2018)
    “…Peptide-YY (PYY) and Glucagon-Like Peptide-1 (GLP-1) play important roles in the regulation of food intake and insulin secretion, and are of translational…”
    Get full text
    Journal Article
  2. 2

    Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity by Worthington, J J, Reimann, F, Gribble, F M

    Published in Mucosal immunology (2018)
    “…The intestinal epithelium must balance efficient absorption of nutrients with partitioning commensals and pathogens from the bodies’ largest immune system. If…”
    Get full text
    Journal Article
  3. 3

    Glucagon-like peptide 1 (GLP-1) by Müller, T.D., Finan, B., Bloom, S.R., D'Alessio, D., Drucker, D.J., Flatt, P.R., Fritsche, A., Gribble, F., Grill, H.J., Habener, J.F., Holst, J.J., Langhans, W., Meier, J.J., Nauck, M.A., Perez-Tilve, D., Pocai, A., Reimann, F., Sandoval, D.A., Schwartz, T.W., Seeley, R.J., Stemmer, K., Tang-Christensen, M., Woods, S.C., DiMarchi, R.D., Tschöp, M.H.

    Published in Molecular metabolism (Germany) (01-12-2019)
    “…The glucagon-like peptide-1 (GLP-1) is a multifaceted hormone with broad pharmacological potential. Among the numerous metabolic effects of GLP-1 are the…”
    Get full text
    Journal Article
  4. 4

    Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion by Parker, H. E., Adriaenssens, A., Rogers, G., Richards, P., Koepsell, H., Reimann, F., Gribble, F. M.

    Published in Diabetologia (01-09-2012)
    “…Aims/hypothesis Several glucose-sensing pathways have been implicated in glucose-triggered secretion of glucagon-like peptide-1 (GLP-1) from intestinal L…”
    Get full text
    Journal Article
  5. 5

    The glucose-dependent insulinotropic polypeptide signaling axis in the central nervous system by Adriaenssens, A.E., Gribble, F.M., Reimann, F.

    Published in Peptides (New York, N.Y. : 1980) (01-03-2020)
    “…•Glucose-dependent insulinotropic polypeptide receptor (GIPR) is expressed in feeding centres.•GIPR+ cell activation inhibits food intake, yet inhibiting GIPR…”
    Get full text
    Journal Article
  6. 6

    Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells by Habib, A. M., Richards, P., Rogers, G. J., Reimann, F., Gribble, F. M.

    Published in Diabetologia (01-06-2013)
    “…Aims/hypothesis Targeting the secretion of gut peptides such as glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) is a strategy under development for the…”
    Get full text
    Journal Article
  7. 7

    Preproglucagon neurons project widely to autonomic control areas in the mouse brain by Llewellyn-Smith, I.J, Reimann, F, Gribble, F.M, Trapp, S

    Published in Neuroscience (28-04-2011)
    “…Abstract Glucagon-like peptide 1 (GLP-1) and its analogue exendin-4 inhibit food intake, reduce blood glucose levels and increase blood pressure and heart rate…”
    Get full text
    Journal Article
  8. 8

    Molecular mechanisms underlying bile acid‐stimulated glucagon‐like peptide‐1 secretion by Parker, HE, Wallis, K, le Roux, CW, Wong, KY, Reimann, F, Gribble, FM

    Published in British journal of pharmacology (01-01-2012)
    “…BACKGROUND AND PURPOSE The glucagon‐like peptides GLP‐1 and GLP‐2 are secreted from enteroendocrine L‐cells following nutrient ingestion. Drugs that increase…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells by Parker, H. E, Habib, A. M, Rogers, G. J, Gribble, F. M, Reimann, F

    Published in Diabetologia (01-02-2009)
    “…Aims/hypothesis Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone with anti-apoptotic effects on the pancreatic beta cell. The aim of…”
    Get full text
    Journal Article
  11. 11

    Sulphonylurea action revisited: the post-cloning era by GRIBBLE, F. M, REIMANN, F

    Published in Diabetologia (01-07-2003)
    “…Hypoglycaemic agents such as sulphonylureas and the newer group of "glinides" stimulate insulin secretion by closing ATP-sensitive potassium (K(ATP)) channels…”
    Get full text
    Journal Article
  12. 12

    Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4 by Casas, S, Novials, A, Reimann, F, Gomis, R, Gribble, F. M

    Published in Diabetologia (01-12-2008)
    “…Aims/hypothesis To investigate the mechanism by which human islet amyloid polypeptide (hIAPP) fibril formation results in calcium influx across the plasma…”
    Get full text
    Journal Article
  13. 13

    Somatostatin receptor 5 and cannabinoid receptor 1 activation inhibit secretion of glucose-dependent insulinotropic polypeptide from intestinal K cells in rodents by Moss, C. E., Marsh, W. J., Parker, H. E., Ogunnowo-Bada, E., Riches, C. H., Habib, A. M., Evans, M. L., Gribble, F. M., Reimann, F.

    Published in Diabetologia (01-11-2012)
    “…Aims/hypothesis Glucose-dependent insulinotropic polypeptide (GIP) is an enteroendocrine hormone that promotes storage of glucose and fat. Its secretion from…”
    Get full text
    Journal Article
  14. 14

    Liquid chromatography/mass spectrometry based detection and semi‐quantitative analysis of INSL5 in human and murine tissues by Kay, R.G., Galvin, S., Larraufie, P., Reimann, F., Gribble, F.M.

    Published in Rapid communications in mass spectrometry (15-12-2017)
    “…Rationale Insulin‐like peptide 5 (INSL5) is a hormone produced by enteroendocrine L‐cells in the colon that has recently been implicated in the control of…”
    Get full text
    Journal Article
  15. 15

    Preproglucagon (PPG) neurons innervate neurochemicallyidentified autonomic neurons in the mouse brainstem by Llewellyn-Smith, I.J, Gnanamanickam, G.J.E, Reimann, F, Gribble, F.M, Trapp, S

    Published in Neuroscience (15-01-2013)
    “…Highlights ► GLP-1 neurons directly innervate brainstem cholinergic and monoaminergic neurons. ► GLP-1 may influence satiety via heavy GLP-1 innervation of…”
    Get full text
    Journal Article
  16. 16

    Electrical activity‐triggered glucagon‐like peptide‐1 secretion from primary murine L‐cells by Rogers, G. J., Tolhurst, G., Ramzan, A., Habib, A. M., Parker, H. E., Gribble, F. M., Reimann, F.

    Published in The Journal of physiology (01-03-2011)
    “…Non‐technical summary  Glucagon like peptide 1 (GLP‐1) based therapies are now widely used for the treatment of diabetes. The physiological source of the…”
    Get full text
    Journal Article
  17. 17

    PREPROGLUCAGON (PPG) NEURONS INNERVATE NEUROCHEMICALLY IDENTIFIED AUTONOMIC NEURONS IN THE MOUSE BRAINSTEM by LLEWELLYN-SMITH, I. J, GNANAMANICKAM, G. J. E, REIMANN, F, GRIBBLE, F. M, TRAPP, S

    Published in Neuroscience (15-01-2013)
    “…Preproglucagon (PPG) neurons produce glucagon-like peptide-1 (GLP-1) and occur primarily in the nucleus tractus solitarius (NTS). GLP-1 affects a variety of…”
    Get full text
    Journal Article
  18. 18

    Spinally projecting preproglucagon axons preferentially innervate sympathetic preganglionic neurons by Llewellyn-Smith, I.J, Marina, N, Manton, R.N, Reimann, F, Gribble, F.M, Trapp, S

    Published in Neuroscience (22-01-2015)
    “…Highlights • Spinal GLP-1 axons target primarily sympathetic preganglionic neurons. • Spinal GLP-1 axons innervate interneurons that may regulate sympathetic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Ablation of AMP-activated protein kinase alpha 1 and alpha 2 from mouse pancreatic beta cells and RIP2.Cre neurons suppresses insulin release in vivo by Sun, G, Tarasov, AI, McGinty, J, McDonald, A, Silva Xavier, G, Gorman, T, Marley, A, French, P M, Parker, H, Gribble, F, Reimann, F, Prendiville, O, Carzaniga, R, Viollet, B, Leclerc, I, Rutter, G A

    Published in Diabetologia (01-05-2010)
    “…Aims/hypothesis: AMP-activated protein kinase (AMPK) is an evolutionarily conserved enzyme and a target of glucose-lowering agents, including metformin…”
    Get full text
    Journal Article